Поиск: ASCO2018

Shortening Adjuvant Trastuzumab to 6 Months in Patients With HER2-Positive Early Breast Cancer Is Effective and Reduces Cardiac Toxicities #ASCO2018 http://www.ascopost.com/News/58848 Материал...